InSightec Image Guided Treatment Ltd., - subsidiary of Elbit Medical Imaging
INSIGHTEC, founded in 1999, develops and distributes the Exablate platform which provides non-invasive treatments for a variety of oncology and gynecology indications.
The Exablate platform uses revolutionary MRgFUS technology which combines high intensity focused ultrasound guided by Magnetic Resonance Imaging (MRI).
Focused ultrasound waves, guided by magnetic resonance imaging are used to safely ablate targeted tissue, ensuring a high rate of effectiveness with minimal side effects.
INSIGHTEC is continuously investing and expanding its current and investigational applications, ranging from functional neurosurgery to oncology and gynecology.